Strides Pharma Science Limited - Company Profile

It is a pharma public limited company based in Thane, Maharashtra, India, established in 1990.
1990 Thane, Maharashtra, India Active
Last Updated:
About Strides Pharma Science Limited

Strides Pharma Science Limited, a active public limited company, was established on 28 June 1990 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230MH1990PLC057062. Registered under ROC Roc Mumbai. it is listed on BSE: 532531 and NSE: STAR. It has an authorized capital of ₹218.37 Cr and a paid-up capital of ₹92.17 Cr.

Formerly known as Strides Pharma Sciences Limited, Strides Shasun Limited. It upholds a compliant status. In 2024, it reported revenue of ₹2,225.56 Cr and a net worth of ₹3,561.12 Cr. Employing 2,152 professional, Its leadership includes Homi Rustam Khusrokhan (Director), Vikesh Kumar (Cfo), Manjula Ramamurthy (Nodal Officer). Past directors included Shashank Sinha, Raghunathan Ananthanarayanan, Homi Rustam Khusrokhan. It holds ₹1,880.26 Cr open charges and ₹11,468.30 Cr settled loans. Its latest AGM occurred on 07 August 2025, with the balance sheet filed on 31 March 2025. It is based at Cyber One, Unit No. 902, Sector 30A,, Plot No - 4 & 6, Vashi, Navi Mumbai, Thane, Maharashtra, 400703.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24230MH1990PLC057062

  • Registration Number

    057062

  • Incorporation Date

    28 June 1990

  • Authorized Capital

    ₹218.37 Cr

  • Paid-Up Capital

    ₹92.17 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed (BSE: 532531, NSE: STAR)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 218.37 Cr
  • Paid Up Capital ₹ 92.17 Cr
  • Company Age 35 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1,880.26 Cr
  • Satisfied Charges ₹ 11,468.30 Cr
  • Revenue Growth **** 14.80%
  • Profit Growth **** 1298.78%
  • Ebitda **** 159.22%
  • Net Worth 3.07%
  • Total Assets **** 3.88%
Company report

Strides Pharma Science Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Strides Pharma Science Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Strides Pharma Science Limited?
Current Directors
Name Designation Appointment Date Status
Homi Rustam Khusrokhan Director 18 May 2017 Current
Vikesh Kumar Cfo 01 Jun 2024 Current
Manjula Ramamurthy Nodal Officer 28 Aug 2019 Current
Badree Komandur Managing Director 18 May 2017 Current
Subir Chakraborty Director 01 Jun 2024 Current
Ameet Pratapsinh Hariani Director 01 Feb 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Ceo(Kmp) 18 May 2017 Past
Pramod Abcsdd Additional Director 09 Jan 2020 Past
Pramod Abcsdd Additional Director 15 Sep 2017 Past
Pramod Abcsdd Whole-Time Director 18 May 2017 Past
Pramod Abcsdd Additional Director 19 Jan 2010 Past
Pramod Abcsdd Company Secretary 01 Jun 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Strides Pharma Science.

Strides Pharma Science Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.8% increase. The company also saw a substantial improvement in profitability, with a 1298.78% increase in profit. The company's net worth moved up by a moderate rise of 3.07%.

Strides Pharma Science revenue growth over time
Strides Pharma Science profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
14.80%
*******
*******
*******
*******
Revenue from Operations
*******
16.11%
*******
*******
*******
*******
Total Assets
*******
3.88%
*******
*******
*******
*******
Profit or Loss
*******
1298.78%
*******
*******
*******
*******
Net Worth
*******
3.07%
*******
*******
*******
*******
EBITDA
*******
159.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Strides Pharma Science?

In 2023, Strides Pharma Science had a promoter holding of 28.28% and a public holding of 71.73%. The company had 3 Subsidiaries and 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹18,802,639,310.00

Satisfied Charges

₹114,682,954,840.50

Charges Breakdown by Lending Institutions
  • Others : 1879.62 Cr
  • Hdfc Bank Limited : 0.64 Cr
Latest Charge Details
Date Lender Amount Status
20 Oct 2023 Hdfc Bank Limited ₹6.44 M Open
19 Jul 2016 Others ₹1,879.62 Cr Open
27 Mar 2025 Others ₹100.00 Cr Satisfied
10 Feb 2025 Karnataka Bank Ltd. ₹100.00 Cr Satisfied
26 Sep 2024 State Bank Of India ₹510.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Strides Pharma Science?

Strides Pharma Science has a workforce of 2152 employees as of Nov 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Strides Pharma Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strides Pharma Science's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Strides Pharma Science
Recent Activity within the Organization
  • Charges

    A charge registered on 03 Nov 2020 via Charge ID 100389968 with Hdfc Bank Limited was fully satisfied on 09 Nov 2025. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 19 Sep 2023 via Charge ID 100793392 with Others was fully satisfied on 27 Oct 2025. was documented.

  • Charges

    Progress on A charge registered on 10 Feb 2025 via Charge ID 101057359 with Karnataka Bank Ltd. was fully satisfied on 30 Sep 2025. was documented.

  • Charges

    A charge registered on 27 Mar 2025 via Charge ID 101075943 with Others was fully satisfied on 17 Sep 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 1,879.62 Cr registered on 19 Jul 2016 with Charge ID 100062848 was modified on 26 Aug 2025. was completed.

  • Annual General Meeting

    Progress on Strides Pharma Science Limited last Annual general meeting of members was held on 07 Aug 2025 as per latest MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Strides Pharma Science Limited?

The CIN of Strides Pharma Science Limited is L24230MH1990PLC057062.

Where is Strides Pharma Science Limited headquartered?

Strides Pharma Science Limited is headquartered at Cyber One, Unit No. 902, Sector 30A,, Plot No - 4 & 6, Vashi, Navi Mumbai, Thane, Maharashtra, 400703.

When was Strides Pharma Science Limited incorporated?

Strides Pharma Science Limited was incorporated on 28 June 1990.

Who are the current directors of Strides Pharma Science Limited?
What is the primary industry of Strides Pharma Science Limited?

The primary industry of Strides Pharma Science Limited is Manufacturing.

Is Strides Pharma Science Limited a listed company?

Strides Pharma Science Limited is listed. It is listed on BSE: 532531 and NSE: STAR.

What is the capital structure of Strides Pharma Science Limited?

The authorized capital of Strides Pharma Science Limited is ₹218.37 Cr, and the paid-up capital is ₹92.17 Cr.

What is the compliance status of Strides Pharma Science Limited?

The compliance status of Strides Pharma Science Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available